Inhibition of PMA-induced, LFA-1-dependent lymphocyte aggregation by ADP ribosylation of the small molecular weight GTP binding protein, rho

T Tominaga, K Sugie, M Hirata, N Morii, J Fukata, A Uchida, H Imura, S Narumiya, T Tominaga, K Sugie, M Hirata, N Morii, J Fukata, A Uchida, H Imura, S Narumiya

Abstract

Botulinum C3 exoenzyme specifically ADP-ribosylates a group of ras-related small molecular weight GTP-binding proteins, rho, and inhibits their biological activity. Using this enzyme, we examined the function of rho in PMA-induced activation of lymphocyte function-associated antigen-1 (LFA-1) in a B lymphoblastoid cell line, JY. Northern blot analysis revealed that among the three rho genes, rhoA mRNA was predominantly expressed in JY cells. Consistently, only one [32P]ADP-ribosylated band was found when the lysate of the cells was subjected to ADP ribosylation by C3 exoenzyme. When the cells were cultured with C3 exoenzyme, this substrate was ADP-ribosylated in situ in a time- and concentration-dependent manner. Concomitant with this ADP ribosylation, PMA-induced LFA-1/intercellular adhesion molecule (ICAM)-1-dependent aggregation of JY cells was inhibited. This inhibition was blocked by prior treatment of the enzyme with an anti-C3 monoclonal antibody, and overcome by stimulation with higher concentrations of PMA. The C3 exoenzyme-induced inhibition was not affected by shaking of the cell suspension, while inhibition of aggregation by cytochalasin B was abolished by this procedure, suggesting that the inhibitory effect of the C3 exoenzyme treatment was not due to decrease in cell motility. The C3 exoenzyme treatment affected neither protein phosphorylation in JY cells before and after PMA stimulation, nor affected surface expression of LFA-1 and ICAM-1. These results suggest that rhoA protein works downstream of protein kinase C activation linking PMA stimulation to LFA-1 activation and aggregation in JY cells.

References

    1. EMBO J. 1989 Apr;8(4):1087-92
    1. J Biol Chem. 1989 May 25;264(15):8602-5
    1. J Exp Med. 1989 Nov 1;170(5):1697-713
    1. J Cell Biol. 1989 Dec;109(6 Pt 2):3435-44
    1. Nature. 1989 Dec 14;342(6251):811-3
    1. J Immunol. 1990 Jan 1;144(1):191-7
    1. Nature. 1990 Aug 2;346(6283):425-34
    1. J Cell Biol. 1990 Aug;111(2):721-9
    1. Science. 1990 Aug 10;249(4969):635-40
    1. Nature. 1990 Aug 23;346(6286):719-23
    1. J Cell Biol. 1990 Sep;111(3):1001-7
    1. J Biochem. 1990 May;107(5):769-75
    1. Nature. 1991 Jan 10;349(6305):117-27
    1. J Biol Chem. 1991 Jan 25;266(3):1708-15
    1. Science. 1991 Mar 29;251(5001):1611-3
    1. J Biol Chem. 1991 Apr 25;266(12):7646-50
    1. Mol Cell Biol. 1991 Jul;11(7):3682-90
    1. J Biol Chem. 1991 Oct 15;266(29):19312-9
    1. J Exp Med. 1991 Nov 1;174(5):1227-38
    1. Biochem Biophys Res Commun. 1991 Oct 31;180(2):615-22
    1. Am J Physiol. 1992 Apr;262(4 Pt 1):C916-26
    1. J Biol Chem. 1992 May 5;267(13):8719-22
    1. J Biol Chem. 1992 Jun 15;267(17):11677-80
    1. Cell. 1992 Aug 7;70(3):389-99
    1. J Biol Chem. 1992 Oct 15;267(29):20921-6
    1. Mol Cell Biol. 1993 Jan;13(1):72-9
    1. Nature. 1970 Aug 15;227(5259):680-5
    1. Cell. 1977 Dec;12(4):1133-41
    1. J Cell Biol. 1982 Jan;92(1):69-78
    1. Cell. 1982 Sep;30(2):385-93
    1. Nature. 1986 Apr 10-16;320(6062):531-3
    1. J Exp Med. 1986 May 1;163(5):1132-49
    1. FEBS Lett. 1987 Feb 9;212(1):109-13
    1. Nucleic Acids Res. 1987 Feb 25;15(4):1869
    1. Mol Cell Biol. 1988 Jan;8(1):418-26
    1. Proc Natl Acad Sci U S A. 1988 Jan;85(2):497-501
    1. Nucleic Acids Res. 1988 Mar 25;16(6):2717
    1. J Biol Chem. 1988 Sep 5;263(25):12420-6
    1. Oncogene. 1988 Aug;3(2):231-4
    1. J Biol Chem. 1988 Nov 5;263(31):16303-8
    1. J Biol Chem. 1988 Nov 25;263(33):17255-7
    1. Annu Rev Cell Biol. 1988;4:487-525
    1. Nature. 1989 Oct 19;341(6243):619-24

Source: PubMed

3
Se inscrever